Oncology Clinical Trials in Flint, MI
As of August 2026, 35 paid clinical trials are recruiting for Oncology in Flint, Michigan. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
35 clinical trials for Oncology
·Clear filters·Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
A Study of the TheraBionic P1 Device in Breast Cancer
Registry Study for Radiation Therapy Outcomes
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
Top Research Study Locations in Flint
Researchers run research studies in Flint, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Genesys Hurley Cancer Institute | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 69 |
| Hurley Medical Center | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 60 |
| Cancer Hematology Centers - Flint | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 58 |
| Genesee Hematology Oncology PC | Malignant Solid Neoplasm, Melanoma, Non-Hodgkin Lymphoma | 27 |
| McLaren Cancer Institute-Flint | Metastatic Malignant Neoplasm in the Brain, Stage IV Lung Cancer AJCC v8, Advanced Esophageal Adenocarcinoma | 12 |
| Karmanos Cancer Institute at McLaren Flint | HER2-negative Breast Cancer, Hormone Receptor Positive Tumor, Advanced Breast Cancer | 7 |
| AA Medical Research Center | Aortic Stenosis, Cardiovascular Disease and Lipoprotein(a), Moderate to Severe Chronic Obstructive Pulmonary Disease | 4 |
| Genesee Cancer and Blood Disease Treatment Center | Anatomic Stage IV Breast Cancer AJCC v8, Castration-Resistant Prostate Carcinoma, Elevated CA15-3 or CEA or CA27-29 | 4 |
| McLaren Proton Therapy Center | Breast Cancer, Breast Neoplasm, Breast Tumor | 4 |
| Aa Mrc Llc | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Difficult to Control Hypertension | 3 |
| Michigan State University | Colorectal Cancer, Health Disparities, Maternal Morbidity and Mortality | 3 |
| AA Medical Research Center (MRC) | Atrial Fibrillation (AF) | 2 |
| AA MRC LLC Ahmed Arif Medical Research Center | Systemic Lupus Erythematosus (SLE) | 1 |
| Aa Mrc Mhs | Atherosclerotic Cardiovascular Disease | 1 |
| Ahmed Arif Medical Research Center (AA MRC LLC ) | Atherosclerosis | 1 |
| Aurinia Investigational Site | Myasthenia Gravis, Generalized | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Corazon Imaging | Atherosclerosis, Cardiovascular Inflammation, Coronary Artery Disease | 1 |
| Dermatology & Cosmetic Center PLLC - Flint | Pyoderma Gangrenosum | 1 |
| Dermatology and Cosmetic Center | NonSegmental Vitiligo | 1 |
| Elite Clinical Research Center | Hypothyroidism | 1 |
| Elite Research Center | Type 1 Diabetes Mellitus With Hypoglycemia | 1 |
| Elite Research Center, LLC | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Flint Development Center | Cardiovascular Health, Health Promotion | 1 |
| Flint Journal Building | HPV Vaccination | 1 |
Active & Upcoming Studies in Flint (2026)
Recruiting trials in Flint grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (79 active studies)
- A Study of the TheraBionic P1 Device in Breast Cancer · Barbara Ann Karmanos Cancer Institute
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
Cardiovascular (10 active studies)
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF · Phase 3 · AstraZeneca
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable · Phase 3 · Regeneron Pharmaceuticals
Diabetes & metabolic (3 active studies)
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity · Phase 3 · Pfizer
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Mental health & behavior (2 active studies)
- The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention · Michigan State University
- Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers · University of Michigan
Neurology & pain (2 active studies)
- REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry) · Medtronic Neurovascular Clinical Affairs
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial · Phase 3 · Mercy Health Ohio
Eye & vision (1 active study)
- Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2 · University of Michigan
Common conditions studied in Flint
- Stage IV Lung Cancer AJCC v8 (7 active studies)
- Acute Myeloid Leukemia (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (4 active studies)
- Stage IIIB Lung Cancer AJCC v8 (4 active studies)
Leading research sponsors in Flint
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
- NRG Oncology
- Barbara Ann Karmanos Cancer Institute
Frequently asked questions
How many paid clinical trials are currently recruiting in Flint?
There are approximately 140 recruiting clinical trials in Flint, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Flint pay participants?
Most recruiting trials in Flint compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Flint?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Flint?
The most common conditions under active study in Flint include Stage IV Lung Cancer AJCC v8 (7), Acute Myeloid Leukemia (6), Anatomic Stage II Breast Cancer AJCC v8 (4), Lung Non-Small Cell Carcinoma (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Flint?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Flint on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Flint?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Flint?
Recruiting research sites in Flint include Genesys Hurley Cancer Institute, Hurley Medical Center, Cancer Hematology Centers - Flint, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Flint right now?
The largest active categories in Flint are Cancer & tumors (79), Cardiovascular (10), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.